Amrize (NYSE:AMRZ) Cut to Sell at Wall Street Zen

Wall Street Zen downgraded shares of Amrize (NYSE:AMRZ – Free Report) from a hold rating to a sell rating in a research note released on Saturday,Wall Street Zen reports.

Several other research firms have also recently issued reports on AMRZ. Weiss Ratings cut shares of Amrize from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, October 8th. Zacks Research lowered shares of Amrize from a “hold” rating to a “strong sell” rating in a research report on Wednesday, August 19th. Longbow Research started coverage on shares of Amrize in a research note on Monday, October 12th. They set a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Amrize from $64.00 to $56.00 and set a “buy” rating on the stock in a research report on Wednesday, September 23rd. Finally, Wells Fargo & Company lowered their target price on shares of Amrize from $40.00 to $39.00 and set an “equal weight” rating for the company in a research note on Friday, October 30th. Eight research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat.com, Amrize currently has an average rating of “Hold” and a consensus target price of $47.65.

View Our Latest Stock Report on Amrize

Amrize Stock Performance

NYSE AMRZ opened at $42.98 on Friday. The company has a quick ratio of 0.67, a current ratio of 1.07 and a debt-to-equity ratio of 0.33. Amrize has a fifty-two week low of $35.78 and a fifty-two week high of $65.94. The business has a fifty day moving average of $39.49 and a 200-day moving average of $50.25. The stock has a market cap of $23.77 billion, a price-to-earnings ratio of 19.45, a price-to-earnings-growth ratio of 1.73 and a beta of 0.04.

Amrize (NYSE:AMRZ – Get Free Report) last posted its quarterly earnings data on Wednesday, October 28th. The company reported $1.05 EPS for the quarter, meeting analysts’ consensus estimates of $1.05. The business had revenue of $3.77 billion for the quarter. Amrize had a return on equity of 10.02% and a net margin of 9.93%. The firm’s revenue was up 2.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.98 EPS. As a group, analysts predict that Amrize will post 2.30 earnings per share for the current fiscal year.

Amrize Announces Dividend

The firm also recently declared a dividend, which will be paid on Wednesday, November 18th. Shareholders of record on Tuesday, November 10th will be given a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, November 10th. Amrize’s payout ratio is 4.98%.

Insider Buying and Selling at Amrize

In related news, Director Jacques Sanche acquired 4,150 shares of Amrize stock in a transaction on Wednesday, August 26th. The shares were bought at an average price of $45.02 per share, for a total transaction of $186,833.00. Following the completion of the purchase, the director directly owned 9,766 shares in the company, valued at $439,665.32. This trade represents a 73.90% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Jan Jenisch purchased 26,000 shares of the firm’s stock in a transaction on Wednesday, September 2nd. The stock was bought at an average price of $42.47 per share, with a total value of $1,104,220.00. Following the acquisition, the chief executive officer owned 1,767,000 shares in the company, valued at $75,044,490. This trade represents a 1.49% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have purchased a total of 34,155 shares of company stock worth $1,461,276 in the last 90 days. Company insiders own 0.54% of the company’s stock.

Hedge Funds Weigh In On Amrize

Hedge funds have recently bought and sold shares of the company. Pictet Asset Management Holding SA raised its stake in Amrize by 4.3% during the third quarter. Pictet Asset Management Holding SA now owns 6,126,150 shares of the company’s stock worth $230,110,000 after acquiring an additional 253,512 shares during the period. Allspring Global Investments Holdings LLC boosted its stake in Amrize by 3.7% in the first quarter. Allspring Global Investments Holdings LLC now owns 4,772,941 shares of the company’s stock valued at $263,371,000 after acquiring an additional 171,622 shares during the period. Bank Julius Baer & Co. Ltd Zurich boosted its stake in Amrize by 8.8% in the third quarter. Bank Julius Baer & Co. Ltd Zurich now owns 2,102,975 shares of the company’s stock valued at $78,985,000 after acquiring an additional 170,551 shares during the period. Renaissance Technologies LLC boosted its stake in Amrize by 10.4% in the first quarter. Renaissance Technologies LLC now owns 1,956,600 shares of the company’s stock valued at $109,609,000 after acquiring an additional 183,900 shares during the period. Finally, Amundi grew its holdings in shares of Amrize by 30.9% during the first quarter. Amundi now owns 1,654,739 shares of the company’s stock valued at $92,698,000 after purchasing an additional 390,750 shares during the last quarter.

About Amrize

(Get Free Report)

Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets.

The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects.

Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim’s North American business.

Recommended Stories

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.